Lars J Petersen1,2, Julie B Nielsen3,4, Niels C Langkilde4,5, Astrid Petersen6, Ali Afshar-Oromieh7, Nandita M De Souza8, Katja De Paepe8, Rune V Fisker3,9, Dennis T Arp10, Jesper Carl10,11, Uwe Haberkorn12,13, Helle D Zacho3,4. 1. Department of Nuclear Medicine, Aalborg University Hospital, Hobrovej 18-22, 9000, Aalborg, Denmark. lajp@rn.dk. 2. Department of Clinical Medicine, Aalborg University, Aalborg, Denmark. lajp@rn.dk. 3. Department of Nuclear Medicine, Aalborg University Hospital, Hobrovej 18-22, 9000, Aalborg, Denmark. 4. Department of Clinical Medicine, Aalborg University, Aalborg, Denmark. 5. Department of Urology, Aalborg University Hospital, Aalborg, Denmark. 6. Department of Pathology, Aalborg University Hospital, Aalborg, Denmark. 7. Department of Nuclear Medicine, Bern University Hospital, Bern, Switzerland. 8. The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, UK. 9. Department of Radiology, Aalborg University Hospital, Aalborg, Denmark. 10. Department of Medical Physics, Aalborg University Hospital, Aalborg, Denmark. 11. Department of Oncology, Naestved Sygehus, Zealand University Hospital, Naestved, Denmark. 12. Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany. 13. Clinical Cooperation Unit Nuclear Medicine, DKFZ, Heidelberg, Germany.
Abstract
BACKGROUND: The aim was to compare the diagnostic accuracy of 68Ga-PSMA PET/CT with conventional cross-sectional imaging and diffusion-weighted MRI (DW-MRI) for detecting lymph node metastasis (LNM) to stage prostate cancer patients. Twenty consecutive, newly- diagnosed prostate cancer patients were prospectively enrolled and underwent 68Ga-PSMA-11 PET/CT, anatomical MRI or contrast-enhanced CT, and DW-MRI prior to laparoscopic, template-based, extended lymph node dissection. Histopathological findings served as the reference test. RESULTS: Histopathology showed LNM in 13 of 20 patients (19 high-risk, 1 intermediate risk). Five patients had metastasis-suspected lymph nodes on 68Ga-PSMA PET/CT. Patient-based analysis showed that the sensitivity and specificity for detecting LNM were 39% and 100% with 68Ga-PSMA PET/CT, 8% and 100% with MRI/CT, and 36% and 83% with DW-MRI, respectively. The positive and negative predictive values were 100% and 49% with 68Ga-PSMA PET/C, 100% and 37% with MRI/CT, and 80% and 42% with DW-MRI. Of 573 dissected lymph nodes, 33 were LNM from 26 regions. True-positive LNM on 68Ga-PSMA PET/CT was 9-11 mm in diameter, whereas false-negative LNM had a median diameter of 4 mm, with only 3 of 30 lymph nodes being larger than 10 mm. LNM were positive for PSMA by immunostaining. CONCLUSIONS: The sensitivity of 68Ga-PSMA PET/CT was notably better than that of MRI/CT and comparable to that of DW-MRI. Some false positive findings with DW-MRI reduced its specificity and positive predictive value compared with those of 68Ga-PSMA PET/CT and MRI/CT.
BACKGROUND: The aim was to compare the diagnostic accuracy of 68Ga-PSMA PET/CT with conventional cross-sectional imaging and diffusion-weighted MRI (DW-MRI) for detecting lymph node metastasis (LNM) to stage prostate cancerpatients. Twenty consecutive, newly- diagnosed prostate cancerpatients were prospectively enrolled and underwent 68Ga-PSMA-11 PET/CT, anatomical MRI or contrast-enhanced CT, and DW-MRI prior to laparoscopic, template-based, extended lymph node dissection. Histopathological findings served as the reference test. RESULTS: Histopathology showed LNM in 13 of 20 patients (19 high-risk, 1 intermediate risk). Five patients had metastasis-suspected lymph nodes on 68Ga-PSMA PET/CT. Patient-based analysis showed that the sensitivity and specificity for detecting LNM were 39% and 100% with 68Ga-PSMA PET/CT, 8% and 100% with MRI/CT, and 36% and 83% with DW-MRI, respectively. The positive and negative predictive values were 100% and 49% with 68Ga-PSMA PET/C, 100% and 37% with MRI/CT, and 80% and 42% with DW-MRI. Of 573 dissected lymph nodes, 33 were LNM from 26 regions. True-positive LNM on 68Ga-PSMA PET/CT was 9-11 mm in diameter, whereas false-negative LNM had a median diameter of 4 mm, with only 3 of 30 lymph nodes being larger than 10 mm. LNM were positive for PSMA by immunostaining. CONCLUSIONS: The sensitivity of 68Ga-PSMA PET/CT was notably better than that of MRI/CT and comparable to that of DW-MRI. Some false positive findings with DW-MRI reduced its specificity and positive predictive value compared with those of 68Ga-PSMA PET/CT and MRI/CT.
Authors: Wolfgang Peter Fendler; Jeremie Calais; Martin Allen-Auerbach; Christina Bluemel; Nina Eberhardt; Louise Emmett; Pawan Gupta; Markus Hartenbach; Thomas A Hope; Shozo Okamoto; Christian Helmut Pfob; Thorsten D Pöppel; Christoph Rischpler; Sarah Schwarzenböck; Vanessa Stebner; Marcus Unterrainer; Helle D Zacho; Tobias Maurer; Christian Gratzke; Alexander Crispin; Johannes Czernin; Ken Herrmann; Matthias Eiber Journal: J Nucl Med Date: 2017-04-13 Impact factor: 10.057
Authors: Thomas A Hope; Jeremy Z Goodman; Isabel E Allen; Jeremie Calais; Wolfgang P Fendler; Peter R Carroll Journal: J Nucl Med Date: 2018-12-07 Impact factor: 10.057
Authors: Helle D Zacho; Julie B Nielsen; Ali Afshar-Oromieh; Uwe Haberkorn; Nandita deSouza; Katja De Paepe; Katja Dettmann; Niels C Langkilde; Christian Haarmark; Rune V Fisker; Dennis T Arp; Jesper Carl; Jørgen B Jensen; Lars J Petersen Journal: Eur J Nucl Med Mol Imaging Date: 2018-06-06 Impact factor: 9.236
Authors: Matthias Eiber; Tobias Maurer; Michael Souvatzoglou; Ambros J Beer; Alexander Ruffani; Bernhard Haller; Frank-Philipp Graner; Hubert Kübler; Uwe Haberkorn; Michael Eisenhut; Hans-Jürgen Wester; Jürgen E Gschwend; Markus Schwaiger Journal: J Nucl Med Date: 2015-03-19 Impact factor: 10.057
Authors: Laura Van den Bergh; Evelyne Lerut; Karin Haustermans; Christophe M Deroose; Raymond Oyen; Sofie Isebaert; Tom Budiharto; Filip Ameye; Felix M Mottaghy; Kris Bogaerts; Hendrik Van Poppel; Steven Joniau Journal: Urol Oncol Date: 2015-02-02 Impact factor: 3.498
Authors: Pim J van Leeuwen; Louise Emmett; Bao Ho; Warick Delprado; Francis Ting; Quoc Nguyen; Phillip D Stricker Journal: BJU Int Date: 2016-06-18 Impact factor: 5.588
Authors: Wolfgang P Fendler; Jeremie Calais; Matthias Eiber; Robert R Flavell; Ashley Mishoe; Felix Y Feng; Hao G Nguyen; Robert E Reiter; Matthew B Rettig; Shozo Okamoto; Louise Emmett; Helle D Zacho; Harun Ilhan; Axel Wetter; Christoph Rischpler; Heiko Schoder; Irene A Burger; Jeannine Gartmann; Raven Smith; Eric J Small; Roger Slavik; Peter R Carroll; Ken Herrmann; Johannes Czernin; Thomas A Hope Journal: JAMA Oncol Date: 2019-06-01 Impact factor: 31.777
Authors: Simona Malaspina; Mikael Anttinen; Pekka Taimen; Ivan Jambor; Minna Sandell; Irina Rinta-Kiikka; Sami Kajander; Jukka Schildt; Ekaterina Saukko; Tommi Noponen; Jani Saunavaara; Peter B Dean; Roberto Blanco Sequeiros; Hannu J Aronen; Jukka Kemppainen; Marko Seppänen; Peter J Boström; Otto Ettala Journal: Eur J Nucl Med Mol Imaging Date: 2021-03-13 Impact factor: 9.236
Authors: Sui Wai Ling; Anouk C de Jong; Ivo G Schoots; Kazem Nasserinejad; Martijn B Busstra; Astrid A M van der Veldt; Tessa Brabander Journal: Eur Urol Open Sci Date: 2021-09-28